Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
|
|
Integrated Regional Information Networks - December 20, 2004
JOHANNESBURG (PLUSNEWS) - South African AIDS lobby group, the Treatment Action Campaign (TAC), has accused the national health department of trying to undermine public health with its "unscientific, irresponsible and inaccurate statement" on the anti-AIDS drug, Nevirapine, after recent US media reports on the safety of the drug.
Last week the Associated Press published reports highlighting flaws in the way the US National Institutes of Health (NIH) had communicated problems with the HIVNET 012 Nevirapine trial in Uganda in 2002. The trial investigated the drug's safety and efficacy in preventing mother-to-child HIV transmission.
According to a local newspaper, Business Day, top NIH officials were warned that the researchers had under-reported thousands of severe reactions, including deaths.
The South African health department welcomed "further questioning [of] the safety of Nevirapine", but TAC accused the department of a "continued misinformation campaign on Nevirapine", and said it was taking legal advice on the matter.
041220
IR041269
Copyright © 2004 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980 – 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .